Salesforce
AI Intelligence Briefcase
Synthesize all available public data, government contracts, patent filings, and funding rounds for Salesforce into a comprehensive strategic report.
Government Contracts & Awards
Proprietary Tech & Patents
No recent patents found.
Form D Funding
No recent SEC Form D filings found.
Market Intelligence & News
Top Research Reports for UnitedHealth, BlackRock & Salesforce
UnitedHealth, BlackRock and Salesforce lead today's featured research, highlighting growth drivers, key risks and analyst views shaping each outlook.
Here Are Monday’s Best Wall Street Analyst Research Calls: Adobe, Applovin, Casey’s General Stores, CrowdStrike, Honeywell Aerospace, Salesforce, Synaptics, Terawulf, and More
Pre-Market Stock Futures: Futures are trading higher as we get ready to start a holiday-shortened trading week, with the Federal 4th of July holiday scheduled for Friday, before we celebrate the 250th anniversary of the country on Saturday. Futures are higher after reports that the U.S. and Iran have agreed to halt hostilities, which we ... Here Are Monday’s Best Wall Street Analyst Research Calls: Adobe, Applovin, Casey’s General Stores, CrowdStrike, Honeywell Aerospace, Salesforce, Synaptics,
Look Past the AI Hype: The Cold, Hard Financial Metric Telling You Exactly Which Enterprise Software Giant to Buy Right Now
Salesforce (NYSE:CRM) and Palantir (NASDAQ:PLTR) both delivered blowout quarters this spring, yet the market punished each stock. Salesforce posted $11.13B in revenue, up 13.3% YoY, leaning on Agentforce momentum. Palantir countered with 85% revenue growth and a Rule of 40 score of 145. Despite the strong headline numbers, the valuation math diverges sharply between the ... Look Past the AI Hype: The Cold, Hard Financial Metric Telling You Exactly Which Enterprise Software Giant to Buy Right Now
Why Salesforce Stock Bumped Higher on a Lousy Tuesday for the Market
An analyst reiterated his very sunny outlook on the CRM king's future.
Palantir and Salesforce put software's rebound on trial: AlphaCheck
Until both stocks reclaim key levels, software's rebound is still awaiting a verdict.
Why Salesforce (CRM) Shares Are Sliding Today
Shares of CRM software giant Salesforce (NYSE:CRM) fell 1.8% in the afternoon session after a confluence of high-profile AI talent departures from Alphabet, and a regulatory overhang pulled the entire communication-services and software complex lower. Alphabet fell roughly 6%.
SpaceX, Micron, Salesforce, Fervo, and More Stocks That Explain Today’s Market
Micron and Intel are heading for further records, while SpaceX, Alphabet, and other big tech names decline.
Oracle vs. Salesforce: Which Tech Giant Is The Better Buy?
Salesforce (NYSE: CRM) and Oracle (NYSE: ORCL) both delivered fresh earnings inside a three week window, and the contrast is striking. Salesforce sells AI agents that sit on top of customer data. Oracle sells the cloud plumbing those agents increasingly run on. Both are leaning into generative AI, but the way each one funds, prices, ... Oracle vs. Salesforce: Which Tech Giant Is The Better Buy?
Salesforce (CRM) Inks Definitive Agreement for Fin Acquisition
Salesforce (NYSE:CRM) is one of the 8 Best Generative AI Software Stocks to Buy in June. On June 15, Salesforce announced that it had forged a definitive agreement for the acquisition of customer agent company Fin, formerly Intercom, for approximately $3.6 billion. Salesforce said the acquisition will bring Fin’s customer agent platform to companies of […]
Salesforce upgraded to Buy at Monness as valuation “now compelling”
Investing.com -- Monness, Crespi, Hardt upgraded Salesforce to Buy from Neutral in a note on Thursday, arguing that fears over artificial intelligence displacing the company are overblown and that the stock's decline has created a compelling entry point.
Factual Connections
Connections to other companies, executives, and politicians — sourced from disclosed trades, shared officers/directors, and public filings — are a Pro/Alpha feature.
Upgrade to Pro